Anzeige
Erschienen in:
18.04.2023 | Clinical Investigation
Prevalence and severity of diabetic retinopathy at first presentation to vitreoretinal services in Bhutan: a 3-year national study
Erschienen in: Japanese Journal of Ophthalmology | Ausgabe 3/2023
Einloggen, um Zugang zu erhaltenAbstract
Purpose
To determine the prevalence and severity of diabetic retinopathy (DR) at first presentation among diabetic patients attending national vitreoretinal (VR) services in Bhutan
Study design
Retrospective cross-sectional study
Methods
We included all diabetic patients in Bhutan who presented for retinal evaluation for the first time over a 3-year period (2013–2016). Data including demography, clinical details, diagnostic tests, and clinical staging of DR were analyzed.
Results
A total of 843 diabetic patients, aged 57.2 ± 12.0 (range 18–86) years, were enrolled. The majority were male (452, 53.6%; cumulative frequency [cf] 391, 46.4%; P = .14) and from urban settings (570, 67.6%; cf 273; 32.4%) and did not have modern schooling (555, 65.8%). Hypertension was the most common systemic comorbidity (501, 59.4%). The prevalence of DR was 42.7%, with mild nonproliferative DR (NPDR) being the most common type (187, 51.9%), followed by moderate NPDR (88, 24.4%) and proliferative DR (45, 12.5%). In addition, 120 patients had clinically significant macular edema (CSME), with a prevalence of 14.2%. Best-corrected visual acuity (BCVA) of 6/60 or worse occurred in 231 eyes (13.7%), and 41 patients (4.86%) had BCVA of 6/60 or worse bilaterally due to DR/CSME. A logistic regression model indicated that the major determinant of DR was the duration of diabetes, the odds rising by 1.27× with each year of disease (P < .0001).
Conclusion
The prevalence of DR, including CSME, was high. Although a national DR screening program is established in Bhutan, there is a need to accelerate health education, community screening, and referral systems to reduce the prevalence of DR and CSME.